| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.005 |